List of GLP-1 receptor agonists: difference between revisions
Diff·revision 10 → 11·01:24, 11 Jan 2025
Difference between revision 10 and revision 11 of List of GLP-1 receptor agonists. 6 lines changed; the page grew by 157 bytes.
| Revision 10 — 05:06, 19 Dec 2024 RetatrutideRuben (talk) de-orphan 2,866 bytes +260 | Revision 11 — 01:24, 11 Jan 2025 Chromatokid (talk) add see-also entries for the four articles that link here 3,023 bytes +157 | ||
|---|---|---|---|
| 42 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> | 42 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> |
| 43 | 43 | ||
| + | 44 | == See also == | |
| + | 45 | * [[GLP-1 receptor agonist]] | |
| + | 46 | * [[Comparison of GLP-1 receptor agonists]] | |
| + | 47 | * [[Dual incretin agonist]] | |
| + | 48 | * [[Timeline of incretin therapeutics]] | |
| + | 49 | ||
| 44 | {{DEFAULTSORT:List of GLP-1 receptor agonists}} | 50 | {{DEFAULTSORT:List of GLP-1 receptor agonists}} |
| 45 | [[Category:Lists]] | 51 | [[Category:Lists]] |